What is the Impact Factor of Nature Reviews Drug Discovery?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Nature Reviews Drug Discovery is 91.2, ranking in quartile Q1 of Web of Science (SCIE).

Is Nature Reviews Drug Discovery indexed in Web of Science or Scopus?

Yes, Nature Reviews Drug Discovery is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 32.6 (Q1) and an H-index of 428.

Who publishes Nature Reviews Drug Discovery and what is the Article Processing Charge (APC)?

Nature Reviews Drug Discovery is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $5,947 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Nature Reviews Drug Discovery?

The official ISO-4 abbreviation of Nature Reviews Drug Discovery is "NAT. REV. DRUG DISCOVERY" with common acronym "nrdd". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #4Top JournalReview JournalHybrid

Nature Reviews Drug Discovery

Acronym:nrdd

•

Abbreviation (ISO):NAT. REV. DRUG DISCOVERY

•

Identifier (ISSN):1474-1776(Print)/1474-1784(Online)

•

Publisher:Springer Nature

Official Website Submission Portal Compare

Clarivate IF (2026)

91.2↓ -10.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Nature Reviews Drug Discovery

WoS Q1

Annual Impact Factor Metric

Current (2026):91.2

Scopus SJR & RankScopus Q1

32.577

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

428

428 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate0.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

38articles/year

6.48% Gold OA•19.44% Original Research

Aims & Scope

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering a broad scope, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in areas such as new drug approvals, patent law and emerging industry trends and strategies.

Topics Covered (Recognized by AI)

BiologyMedicineChemistryPharmacologyBiochemistryGeneticsInternal MedicineComputational BiologyPsychologyBioinformaticsPsychiatryComputer SciencePathologyBusiness

Primary Research Areas

Medicine Biotechnology & Applied Microbiology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank1/180

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank1/356

IndexSCIE

JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank1/180

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank1/356

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	1/180	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	1/356	Q1
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	1/180	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	1/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF91.2

Articles / Year185

Total Citations184

2025

IF101.8

Articles / Year241

Total Citations2,986

2024

IF122.7

Articles / Year244

Total Citations6,808

2023

IF120.1

Articles / Year244

Total Citations10,856

2022

IF112.288

Articles / Year243

Total Citations20,917

Year	Impact Factor	Articles / Year	Total Citations
2026	91.2	185	184
2025	101.8	241	2,986
2024	122.7	244	6,808
2023	120.1	244	10,856
2022	112.288	243	20,917
2021	84.694	247	36,232
2020	64.797	251	35,062
2019	57.618	242	35,848
2018	50.167	245	33,868
2017	—	283	32,098
2016	—	278	32,370
2015	—	290	30,921

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4Scopus Q1SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

32.577

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

15.31

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$5,947 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,533

3-Year Documents716

Citable Documents117

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)6

Citations in government and international policy documents

Female Author Rate30.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1

Medicine (miscellaneous)Q1

PharmacologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区BIOTECHNOLOGY & APPLIED MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Nature Reviews Drug Discovery (acronym: nrdd, abbr: NAT. REV. DRUG DISCOVERY, ISSN: 1474-1776) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 91.2, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 32.6 (Q1), an H-index of 428.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 38 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $5,947 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.